{"action":"elsewhere","city":"Wilmington","companyRegistrationNumber":null,"conformityFlag":"NON_CONFORMING","country":"US","createdAt":"2017-01-24T00:00:00.000Z","entityCategory":"GENERAL","entityStatus":"ACTIVE","entitySubCategory":null,"expirationReason":null,"expiredAt":null,"family":{"children":[],"childrenTotal":0,"exceptions":[{"category":"DIRECT_ACCOUNTING_CONSOLIDATION_PARENT","reasons":["NON_CONSOLIDATING"],"references":[]},{"category":"ULTIMATE_ACCOUNTING_CONSOLIDATION_PARENT","reasons":["NON_CONSOLIDATING"],"references":[]}],"parents":[]},"headquartersAddress":"601 Gateway Boulevard, Suite 350","headquartersCity":"San Francisco","headquartersCountry":"US","headquartersPostalCode":"94080","headquartersRegion":"US-CA","lastUpdatedAt":"2024-05-22T13:30:05.998Z","legalAddress":"c/o The Corporation Trust Company, Corporation Trust Center, 1209 Orange St","legalFormAbbreviation":null,"legalFormCode":"XTIQ","legalFormName":"Corporation","legalJurisdiction":"US-DE","legalName":"AKERO THERAPEUTICS, INC.","lei":"549300SI3KG74LBE2955","managingLou":"5493001KJTIIGC8Y1R12","managingLouName":"Bloomberg","managingLouWebsite":"http://lei.bloomberg.com","nextRenewalAt":"2024-05-22T06:41:52.536Z","otherLegalForm":null,"postalCode":"19801","region":"US-DE","registeredAt":"2019-06-03T14:33:00.000Z","registrationAuthorityId":"RA000602","registrationAuthorityName":"Division of Corporations, Department of State","registrationAuthorityWebsite":"https://corp.delaware.gov/","registrationNumber":"6294543","registrationNumberFormatted":"6294543","registrationStatus":"LAPSED","served":false,"successorLeis":[],"validationAuthorityEntityId":"6294543","validationAuthorityId":"RA000602","validationAuthorityName":"Division of Corporations, Department of State","validationSources":"FULLY_CORROBORATED"}